Can Buscopan (hyoscine butylbromide) be given with Ranitidine and Stemetil (prochlorperazine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Buscopan (hyoscine butylbromide), ranitidine, and Stemetil (prochlorperazine) can generally be given together, but this combination should only be used under medical supervision. These medications work differently in the body: Buscopan relieves abdominal cramps by relaxing smooth muscle, ranitidine reduces stomach acid production, and Stemetil treats nausea and vomiting. While there are no major interactions between these specific medications, individual factors like your medical history, other medications you're taking, and your specific condition need consideration. Potential side effects when combining these medications include dry mouth, constipation, drowsiness, and blurred vision. Dosing would depend on your specific condition and should be determined by your healthcare provider. If you're experiencing gastrointestinal symptoms requiring multiple medications, it's essential to seek proper medical evaluation to address the underlying cause rather than just treating symptoms. According to 1, scopolamine, which is structurally similar to hyoscine butylbromide, has a limited bioavailability if orally administered and may have adverse effects such as dry mouth, drowsiness, and blurred vision. Additionally, 2 suggests that hyoscine N-butyl bromide can be combined with other medications, such as tramadol, in infusion solutions without significant losses or incompatibilities. However, it's crucial to prioritize the most recent and highest-quality study, which in this case is not directly related to the combination of Buscopan, ranitidine, and Stemetil. Therefore, the decision to use this combination should be based on individual patient needs and medical supervision, considering the potential benefits and risks, as well as the lack of direct evidence on this specific combination.

References

Research

Tramadol and hyoscine N-butyl bromide combined in infusion solutions: compatibility and stability.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.